welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Catabasis Quarterly: Updates on edasalonexent and clinical trials

We are pleased to announce that we have initiated our Phase 3 PolarisDMD clinical trial with edasalonexent in Duchenne muscular dystrophy and we are excited for the sites to begin enrolling participants ages 4 to 7 years old (up to 8th birthday), any mutation type, who have not been taking steroids for at least 6 months. We are not enrolling boys taking steroids due to a potential partial overlap in mechanism. As soon as a site has the required approvals, enrollment at that site can begin. In the coming days additional inclusion and exclusion criteria as well as the sites that are ready to begin enrollment and contact information will be available on www.clinicaltrials.gov.

Catabasis Quarterly: Updates On Edasalonexent And Clinical Trials